Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium; Infla-Med Research Consortium of Excellence, University of Antwerp, Antwerp, Belgium.
Microbiome Research Centre, St George and Sutherland Clinical School, University of New South Wales, Sydney, NSW, Australia.
Lancet Gastroenterol Hepatol. 2022 May;7(5):455-471. doi: 10.1016/S2468-1253(21)00431-3.
Mucins are the gatekeepers of the mucosal barrier of the gastrointestinal tract and are aberrantly expressed in various gastrointestinal pathologies, including pathogen infection, inflammation, and uncontrolled growth and spread of abnormal cells. Although several studies have emphasised the role of mucins in dysfunction of the gastrointestinal mucosal barrier, they are often still considered to be passive mediators of this barrier instead of regulators or modulators. In this Review, we discuss the interactions between mucins and gastrointestinal barrier function during health and disease. We will focus on the bidirectional relationship between mucins and the gut microbiota and will also address the molecular mechanisms involved in key cell signalling pathways, such as inflammation, cell interactions, and cell differentiation, proliferation, and survival. Additionally, we highlight the potential use of mucins in the diagnosis, follow-up, and treatment of gastrointestinal diseases, such as chronic inflammatory diseases and cancer.
黏蛋白是胃肠道黏膜屏障的守门员,在各种胃肠道疾病中异常表达,包括病原体感染、炎症以及异常细胞的失控生长和扩散。尽管有几项研究强调了黏蛋白在胃肠道黏膜屏障功能障碍中的作用,但它们通常仍被认为是该屏障的被动介质,而不是调节者或调节剂。在这篇综述中,我们讨论了黏蛋白在健康和疾病期间与胃肠道屏障功能的相互作用。我们将重点讨论黏蛋白与肠道微生物群之间的双向关系,并探讨涉及关键细胞信号通路的分子机制,如炎症、细胞相互作用以及细胞分化、增殖和存活。此外,我们还强调了黏蛋白在胃肠道疾病(如慢性炎症性疾病和癌症)的诊断、随访和治疗中的潜在用途。